Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp163 | Cell biology: osteoblasts and bone formation | ECTS2013

Hepatic lipase is expressed by osteoblasts and modulates bone remodeling in obesity

Bartelt Alexander , Beil F Timo , Muller Brigitte , Kohne Till , Heine Markus , Yilmaz Tayfun , Heeren Joerg , Schinke Thorsten , Niemeier Andreas

Here we identify the lipolytic enzyme hepatic lipase (HL, encoded by Lipc) as a novel cell-autonomous regulator of osteoblast function. In an unbiased genome-wide expression analysis, we find Lipc – which was formerly thought to be expressed almost exclusively by the liver – to be highly induced upon osteoblast differentiation, as verified by quantitative Taqman analyses of primary osteoblasts in vitro and of bone samples in vivo. ...

ba0005p420 | Other diseases of bone and mineral metabolism | ECTS2016

Calcification in the vessel wall: impact of vitamin K dependent proteins

Schweighofer Natascha , Aigelsreiter Ariane , Trummer Olivia , Kniepeiss Daniela , Wagner Doris , Stiegler Philipp , Pieber Thomas , Muller Helmut , Obermayer-Pietsch Barbara

Pathophysiological calcification in the vasculature favours cardio- and cerebrovascular diseases. In patients with chronic kidney disease vitamin K metabolites are associated with decreased vascular calcification.We investigated the expression of vitamin K dependent proteins (VKDPs) in vessels and bone to identify differences in expression pattern during atherosclerosis (AS) stages and compare the two tissue profiles.Gene expressio...

ba0006p172 | (1) | ICCBH2017

Bone health at 11–12 years, physical activity and sedentariness: a cross-sectional Australian population-based study

Osborn William , Simm Peter , Olds Tim , Lycett Kate , Mensah Fiona , Muller Josh , Fraysse Francois , Ismail Najmi , Vlok Jennifer , Wake Melissa

Objectives: Activity duration and the daily patterns of activity during childhood and adolescence could contribute to long-term bone health. We examined cross-sectional associations between 11 and 12 year old children’s bone health and (1) durations, (2) patterns, and (3) combined durations and patterns of moderate-vigorous physical activity (MVPA) and sedentary behaviour.Methods: Design: Population-based cross-sectional study nested within...

ba0001pp101 | Calciotropic and phosphotropic hormones and mineral metabolism | ECTS2013

Vasculature and bone: stages of atherosclerosis come along with changes in gene expression levels of calcification regulators

Schweighofer Natascha , Aigelsreiter Ariane , Graf-Rechberger Martina , Hacker Nicole , Kniepeiss Daniela , Stiegler Philipp , Trummer Olivia , Pieber Thomas , Ulbing Matthias , Wagner Doris , Muller Helmut , Obermayer-Pietsch Barbara

Calcification in the vasculature is one of the leading causes of cardiovascular diseases and mortality outcomes. Therefore, the aim of our study was to investigate changes in the gene expression of calcification regulators (CR) in arterial vessels during different stages of atherosclerosis and to document potential corresponding changes in the bone. OPG, RANKL, OPN, MGP, BSP-II and RUNX2 were candidate genes for our study in bone, aorta and arteria ilica externa tissue samples...

ba0003pp383 | Other diseases of bone and mineral metabolism | ECTS2014

MicroRNAs as new biomarkers for monitoring of vascular calcification in CKD patients

Ulbing Matthias , Schweighofer Natascha , Leber Bettina , Lemesch Sandra , Rosenkranz Alexander , Eller Kathrin , Kirsch Alexander , Muller Helmut , Stadlbauer Vanessa , Obermayer-Pietsch Barbara

Introduction: Calcification of vessels, especially media calcification, in combination with bone demineralization and disturbed bone metabolism is abundant in patients suffering from end stage renal disease (ESRD). In this project, we compare biomarkers of calcification with a focus on microRNAs from ESRD patients listed for renal transplantation (RTX) and healthy controls.Methods: Samples are collected from kidney transplant patients. At the same time t...

ba0005p123 | Cancer and bone: basic, translational and clinical | ECTS2016

The SRC kinase inhibitor saracatinib limits the development of osteolytic bone disease in multiple myeloma

Heusschen Roy , Muller Josephine , Binsfeld Marilene , Plougonven Erwan , Mahli Nadia , Carmeliet Geert , Leonard Angelique , Cohen-Solal Martine , Vanderkerken Karin , Beguin Yves , Menu Eline , Caers Jo

Destructive bone lesions due to osteolytic bone disease (OBD) are a major cause of morbidity and mortality in multiple myeloma (MM) patients and the development of new therapeutic strategies is of great interest. In this study, we assessed the effect of SRC inhibition with saracatinib (AZD0530, AstraZeneca) on the development of MM and its associated OBD. We first determined SRC family kinase expression in the MM microenvironment and found that myeloma cells express SRC at low...

ba0003pp366 | Other diseases of bone and mineral metabolism | ECTS2014

Gene expression in vascular calcification: are there differences between atherosclerotic changes and media sclerosis?

Schweighofer Natascha , Aigelsreiter Ariane , Graf-Rechberger Martina , Hacker Nicole , Iberer Florian , Kniepeiss Daniela , Wagner Doris , Stiegler Philipp , Gutschi Jurgen , Trummer Olivia , Sinner Frank , Pieber Thomas , Muller Helmut , Obermayer-Pietsch Barbara

Background: Pathophysiological calcification in the vasculature is a risk factor for cardiovascular disease (CVD). CVD are among the most common causes of death in patients with chronic kidney disease and crucial for kidney transplantation (RTX) outcomes.Aim: The aim of this study is to identify differences in the pattern and the onset of expression of regulators of calcification (RC) in atherosclerosis (AS) and media sclerosis (MS).<p class="abstext...

ba0001pp236 | Cell biology: osteoclasts and bone resorption | ECTS2013

Osteoclast resorptive surface: correlation of structure and function

Szewczyk Kinga , Fuller Karen , Chambers Timothy

Despite its importance, the resorptive surface of osteoclasts has not been directly visualised. We exploited a novel approach that enables us to inspect the substrate-apposed surface of cells. To achieve this, we incubated osteoclasts on vitronectin-coated nail varnish and, afterwards, we dissolved the substrate and visualised the cells resorbing-side up in the scanning electron microscope (SEM). We then employed confocal microscopy to correlate the SEM appearances with the di...

ba0007p139 | (1) | ICCBH2019

Growth hormone therapy in a child with severe short stature due to Miller-McKusick-Malvaux (3M) syndrome-2

Seneviratne Sumudu , Silva Deepthi de , Cottrell Emily , Kuruppu Piumi , Silva KSH de , Storr Helen

Background: 3M syndrome is a primordial growth disorder caused by mutations in CUL7, OBSL1 or CCDC8. Affected individuals have severe short stature for which growth hormone (GH) therapy may have a role1. We present a 10-year-old girl from Sri Lanka with 3M syndrome-2 due to a mutation in OBSL1 gene, with good short-term response to growth hormone therapy.Presenting Problem: The only child of second-degree consanguineous parents, both themselve...

ba0007p201 | (1) | ICCBH2019

Juvenile dermatomyositis (JDM) and hypoparathyroidism (HP) in an adolescent girl

Miller Jennifer , Zimmerman Donald

Background: JDM is a systemic autoimmune inflammatory myopathy consisting of symmetric proximal muscle weakness, heliotrope and/or malar rash, Gottron’s papules, nailfold capillary changes, myalgias, arthralgias, dysphonia, dysphagia, fever, anorexia, and calcinosis. Hypoparathyroidism can present with signs of hypocalcemia (numbness, tingling, bronchospasm, seizure, or tetany). Causes of HP include postoperative, autoimmune (isolated or in autoimmune polyglandular syndro...